Document is current
Any future updates will be listed below
-
Authors
Zhan, Guangjie
Wei, Tiantian
Xie, Huichen
Xie, Xiaoming
Hu, Jun
Tang, Hao
Cheng, Yating
Liu, Huaifeng
Li, Shujing
Yang, Guohua
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (81660718)
National Natural Science Foundation of China (31800996)
Project of Hubei Provincial Key Laboratory of Occurrence and Intervention of Rheumatic Diseases (PT022101)
- License Information
-
More Information
Article History
Received: 29 April 2023
Accepted: 29 August 2023
First Online: 7 September 2023
Declarations
:
: The authors declare no competing interests.
: The authors of the manuscript entitled “Autophagy inhibition mediated by trillin promotes apoptosis in HCC cells via activation of mTOR/STAT3 signaling” declare that the requirement of the ethical approval is not applicable, since human and/or animal subjects were not conducted in this study.
: The authors of the manuscript entitled “Autophagy inhibition mediated by trillin promotes apoptosis in HCC cells via activation of mTOR/STAT3 signaling” declare that the requirement of the Helsinki Declaration or relevant guidelines for animal experimentation is not applicable, since human and/or animal experiment was not conducted in this study.
: The authors of the manuscript entitled “Autophagy inhibition mediated by trillin promotes apoptosis in HCC cells via activation of mTOR/STAT3 signaling” confirm that written inform consent taken from the patients/volunteers/guardians of the children for this study is not applicable, since patients/volunteers/guardians of the children were not conducted in this study.
